Intrathecal Infusion for Targeted Drug Delivery

Dr. David Schultz presents an interesting overview of targeted drug delivery (TDD) through intrathecal infusion. He discusses the history of neural stimulation, the introduction of spinal opioids, and medication delivery to the spine. Dr. Schultz highlights proper patient selection for TDD, compares TDD to neurostimulation, and discusses its pros and cons. He describes available TDD systems from Medtronic and Flownix, trialing, and surgical implant complications.